Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Oncotarget|April 21, 2017
Tropomyosin-related kinase B mediated signaling contributes to the induction of malignant phenotype of gallbladder cancerMakoto Kawamoto, Hideya Onishi, Keigo Ozono, et al.
Anticancer Research|December 12, 2003
Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusionTakashi Morisaki, Kotaro Matsumoto, Hideo Kuroki, et al.
Anticancer Research|May 30, 2012
Short-term and low-dose prednisolone administration reduces aromatase inhibitor-induced arthralgia in patients with breast cancerMakoto Kubo, Hideya Onishi, Syoji Kuroki, et al.
Cancer Letters|March 25, 2011
Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxel-resistance in colorectal cancerRui Xu, Kenji Nakano, Hironori Iwasaki, et al.
Anticancer Research|November 24, 2005
Combination therapy with tumor cell-pulsed dendritic cells and activated lymphocytes for patients with disseminated carcinomasMitsuo Katano, Takashi Morisaki, Kennichiro Koga, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancerHiroyuki Suzuki, Nobuhito Chikazawa, Takehiko Tasaka, et al.
Anticancer Research|August 1, 2018
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung CancerHideya Onishi, Shu Ichimiya, Kosuke Yanai, et al.
Cellular Immunology|November 2, 2020
NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytesKazunori Nakayama, Hideya Onishi, Akiko Fujimura, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2019
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitorAkiko Fujimura, Kazunori Nakayama, Akira Imaizumi, et al.
Anticancer Research|January 10, 2014
NOTCH4 is a potential therapeutic target for triple-negative breast cancerIori Nagamatsu, Hideya Onishi, Shojiro Matsushita, et al.
Pageof 12